Literature DB >> 18053582

Functional analysis of CD8+ T cell responses to the onconeural self protein cdr2 in patients with paraneoplastic cerebellar degeneration.

Erica L Carpenter1, Barbara A Vance, Rachel S Klein, Alfredo Voloschin, Josep Dalmau, Robert H Vonderheide.   

Abstract

Paraneoplastic cerebellar degeneration (PCD) is linked to an immune response against cerebellar degeneration related antigen 2 (cdr2) co-expressed in tumor and Purkinje neurons. Here, comprehensive immune-assessment assays were used to analyze CD8(+) T cells from 7 PCD patients, but no evidence was found of CD8(+) T cells specific for either of two previously described cdr2 epitopes (cdr2-1 and cdr2-2). In contrast, viral-specific CD8(+) T cells from healthy volunteers and PCD patients were measurable. These findings are inconsistent with an obligate role for cdr2-1- or cdr2-2-specific CD8(+) T cells in the pathogenesis of PCD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18053582     DOI: 10.1016/j.jneuroim.2007.10.014

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  9 in total

1.  CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients.

Authors:  Andrew J Rech; Rosemarie Mick; Sunil Martin; Adri Recio; Nicole A Aqui; Daniel J Powell; Theresa A Colligon; Jennifer A Trosko; Leah I Leinbach; Charles H Pletcher; Carol K Tweed; Angela DeMichele; Kevin R Fox; Susan M Domchek; James L Riley; Robert H Vonderheide
Journal:  Sci Transl Med       Date:  2012-05-16       Impact factor: 17.956

Review 2.  Paraneoplastic syndromes of the CNS.

Authors:  Josep Dalmau; Myrna R Rosenfeld
Journal:  Lancet Neurol       Date:  2008-04       Impact factor: 44.182

Review 3.  Novelties in Autoimmune and Paraneoplastic Cerebellar Ataxias: Twenty Years of Progresses.

Authors:  Sergio Muñiz-Castrillo; Alberto Vogrig; Nicolás Lundahl Ciano-Petersen; Macarena Villagrán-García; Bastien Joubert; Jérôme Honnorat
Journal:  Cerebellum       Date:  2022-01-12       Impact factor: 3.648

Review 4.  'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook.

Authors:  S Jarius; B Wildemann
Journal:  J Neuroinflammation       Date:  2015-09-17       Impact factor: 8.322

5.  Proliferative response of peripheral blood mononuclear cells in anti-Hu antibody-associated patients with paraneoplastic neurological syndrome and their depressant effect on small cell lung cancer cells.

Authors:  Liang Yin; Hongdang Qu; Qiming Chen
Journal:  Mol Med Rep       Date:  2014-11-19       Impact factor: 2.952

6.  Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasis.

Authors:  Manja Schubert; Debabrata Panja; Mette Haugen; Clive R Bramham; Christian A Vedeler
Journal:  Acta Neuropathol       Date:  2014-10-24       Impact factor: 17.088

7.  Anti-Yo antibody-positive paraneoplastic cerebellar degeneration in a patient with possible cholangiocarcinoma: A case report and review of the literature.

Authors:  Yue Lou; Shan-Hu Xu; Si-Ran Zhang; Qin-Fen Shu; Xiao-Li Liu
Journal:  World J Clin Cases       Date:  2021-06-16       Impact factor: 1.337

Review 8.  Paraneoplastic cerebellar degeneration with anti-Yo antibodies - a review.

Authors:  Anand Venkatraman; Puneet Opal
Journal:  Ann Clin Transl Neurol       Date:  2016-06-30       Impact factor: 4.511

Review 9.  A Breakdown of Immune Tolerance in the Cerebellum.

Authors:  Christiane S Hampe; Hiroshi Mitoma
Journal:  Brain Sci       Date:  2022-02-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.